Article Text

Download PDFPDF

OP-057 Comparison of ischemia-modified albumin levels in children with bronchopneumonia and bronchiolitis
Free
  1. Elife Capan Gun1,
  2. Feyza Husrevoglu Esen2,
  3. Yakup Cag1,
  4. Yasemin Akın1,
  5. Nahide Haykır1
  1. 1University of Health Sciences, Kartal Dr.Lütfi Kırdar Training and Research Hospital Department of Pediatrics Istanbul, Türkiye
  2. 2University of Health Sciences, Kartal Dr.Lütfi Kırdar Training and Research Hospital Department of Pediatric Emergency Istanbul, Türkiye

Abstract

Aim Bronchiolitis and bronchopneumonia are important causes of hospitalization in children. Many biomarkers are used in monitoring the clinical course of the disease, grading its severity, and making hospitalization decisions. This study is therefore intended to evaluate the role of ischemia-modified albumin (IMA) level in the differential diagnosis of pneumonia and bronchiolitis and to compare it with other biomarkers used in the diagnosis.

Material and Method Thirty patients with pneumonia and thirty patients with bronchiolitis were included in our study. Patients were diagnosed based on the basis of history, physical examination, posteroanterior chest radiography, as well as serum C-reactive protein (CRP), sedimentation, procalcitonin (PCT), hemogram, and serum IMA levels.

Results In our study, the group of patients with pneumonia had higher levels of CRP, PCT, and serum IMA. CRP (p = 0.001), IMA (p = 0.009), and PCT (p = 0.101) had the highest levels of sensitivity and specificity in the group of patients with pneumonia, respectively. In patients with pneumonia, IMA is more sensitive and specific than PCT (table 1).

Abstract OP-057 Table 1

Comparison of the study variables by group

Conclusions In this study examining pneumonia and bronchiolitis, we think that IMA levels may be an important parameter in making the decision of differential diagnosis of pneumonia and bronchiolitis and to compare it with other biomarkers used in the diagnosis. Given that IMA is similar to other biomarkers cost-wise, IMA may be a more utile parameter in the future.

  • ischemia-modified albumin
  • pneumonia
  • bronchiolitis
  • biomarkers

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.